Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum QLT INC T.QLT

Healthcare Biotechnology
"QLT Inc is a biotechnology company conducts development and commercialization of ocular products that address the unmet medical needs of patients and clinicians."

Bullboard (TSX:QLT)

View:
Prev 1 2 3 Next
Post by clodo1on Sep 22, 2015 5:11pm

Qualcomm`s partner

Take time to visite a winner for 2016. https://www.intrinsyc.com/press-release/intrinsyc-will-distribute-qualcomm-snapdragon-flight-development-board-for-drones-and-robotics/ https://www.intrinsyc ...more  
189
Comment by TheRock07on Mar 02, 2015 11:30am

RE:Very good news

This advanced drug should add about $200 million to the asset value. Watch for a move soon..
123
Discussion
Post by TheRock07on Feb 26, 2015 11:34am

Very good news

During 2014, the Company continued to advance development of QLT091001, its synthetic retinoid product candidate, for the treatment of certain inherited retinal diseases toward pivotal trials ...more  
131
Discussion
Post by prestedon Feb 25, 2015 1:54pm

In and out

I've  been in and out of QLT for years. It never seemed to be able to get there, where there is! However, this seems as good a time to get in as ever since, as has been noted here, it seems ...more  
105
Comment by TheRock07on Feb 10, 2015 4:43pm

RE:RE:$167 US in cash

Nice to see someone else post here. Their drug should be worth $50 million but the real upside will be in the deal..
96
Discussion
Post by TheRock07on Jan 12, 2015 6:37pm

$167 US in cash

The C$ is en route to $0.80 very soon. The $167 million in US cash then becomes over $200 million in cad cash. Onwards and upwards on strong fundamentals
140
Discussion
Comment by TheRock07on Jan 10, 2015 1:46pm

RE:RE:Strong insider Buying

A steady and progressive rise in the share price much as forecast. $6 cannot be too far away...
74
Discussion
Comment by TheRock07on Dec 28, 2014 11:59am

RE:Strong insider Buying

Latest 10 SEDI filings (by transaction date) for QLT within the last 6 months [?] Amended Filing As of 11:59pm ET December 27th, 2014  ...more  
110
Discussion
Post by TheRock07on Dec 23, 2014 7:07am

Strong insider Buying

20,000 shares bought in the past few days. Very good sign
140
Discussion
Post by TheRock07on Dec 16, 2014 7:35am

Although hires Strategic Options consultant

QLT Inc Symbol C : QLT Shares Issued 51,185,922 Close 2014-12-15 C$ 4.06 Recent Sedar ...more  
139
Post by TheRock07on Dec 05, 2014 10:44am

Successful Phase 2 results

QLT Announces Results From Proof-of-Concept Trial With Oral Synthetic cis-Retinoid (QLT091001) in Adult Subjects With Impaired Dark Adaptation and/or Impaired Low Luminance Vision T.QLT, ...more  
94
Post by TheRock07on Dec 02, 2014 10:02pm

A sign that a new arrangement is close

VANCOUVER, British Columbia, Dec. 2, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced that Sukhi Jagpal, Chief Financial Officer ...more  
122
Comment by TheRock07on Oct 29, 2014 8:29pm

RE:share price

That is correct. Nor is their near $100 million US in forward tax loss pools nor their two advanced drugs. easily $7.50 per share
80
Discussion
Post by jseyfferon Oct 28, 2014 10:03am

share price

their buildings and products seem not to be priced in their share price
94
Discussion
Prev 1 2 3 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities